Cross Country Healthcare (CCRN)
Market Price (2/12/2026): $8.33 | Market Cap: $270.9 MilSector: Health Care | Industry: Health Care Facilities
Cross Country Healthcare (CCRN)
Market Price (2/12/2026): $8.33Market Cap: $270.9 MilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -36% | Weak multi-year price returns2Y Excs Rtn is -97%, 3Y Excs Rtn is -142% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -22%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -26%, Rev Chg QQuarterly Revenue Change % is -21% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38% | Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -10.0% | |
| Attractive yieldFCF Yield is 17% | Key risksCCRN key risks include [1] a significant decline in demand for staffing services and [2] regulatory uncertainty surrounding its pending acquisition. | |
| Low stock price volatilityVol 12M is 45% | ||
| Megatrend and thematic driversMegatrends include Healthcare Workforce Innovation, and Healthcare Talent & Labor Market Dynamics. Themes include Clinical Staffing Solutions, Integrated Workforce Management, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -36% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38% |
| Attractive yieldFCF Yield is 17% |
| Low stock price volatilityVol 12M is 45% |
| Megatrend and thematic driversMegatrends include Healthcare Workforce Innovation, and Healthcare Talent & Labor Market Dynamics. Themes include Clinical Staffing Solutions, Integrated Workforce Management, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -97%, 3Y Excs Rtn is -142% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -22%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -26%, Rev Chg QQuarterly Revenue Change % is -21% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -10.0% |
| Key risksCCRN key risks include [1] a significant decline in demand for staffing services and [2] regulatory uncertainty surrounding its pending acquisition. |
Qualitative Assessment
AI Analysis | Feedback
1. Cross Country Healthcare (CCRN) reported disappointing Q3 2025 financial results. On November 12, 2025, the company announced diluted earnings per share (EPS) of $0.03, missing the consensus estimate of $0.04. Additionally, quarterly revenue came in at $250.05 million, falling below analyst estimates of $270.72 million. Consolidated revenue also saw a year-over-year and sequential decrease.
2. The proposed merger between Cross Country Healthcare and Aya Holdings was terminated. This significant event, reported around December 16, 2025, was due to concerns raised by the Federal Trade Commission. The termination of a potential acquisition often leads to investor uncertainty and a decrease in the target company's stock price, as the anticipated benefits of the merger are no longer realized.
Show more
Stock Movement Drivers
Fundamental Drivers
The -32.5% change in CCRN stock from 10/31/2025 to 2/11/2026 was primarily driven by a -28.6% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 2112026 | Change |
|---|---|---|---|
| Stock Price ($) | 12.26 | 8.27 | -32.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,193 | 1,127 | -5.5% |
| P/S Multiple | 0.3 | 0.2 | -28.6% |
| Shares Outstanding (Mil) | 32 | 33 | -0.1% |
| Cumulative Contribution | -32.5% |
Market Drivers
10/31/2025 to 2/11/2026| Return | Correlation | |
|---|---|---|
| CCRN | -32.5% | |
| Market (SPY) | 1.5% | 22.8% |
| Sector (XLV) | 8.3% | 17.4% |
Fundamental Drivers
The -38.5% change in CCRN stock from 7/31/2025 to 2/11/2026 was primarily driven by a -30.9% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2112026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.45 | 8.27 | -38.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,258 | 1,127 | -10.4% |
| P/S Multiple | 0.3 | 0.2 | -30.9% |
| Shares Outstanding (Mil) | 32 | 33 | -0.7% |
| Cumulative Contribution | -38.5% |
Market Drivers
7/31/2025 to 2/11/2026| Return | Correlation | |
|---|---|---|
| CCRN | -38.5% | |
| Market (SPY) | 9.8% | 27.5% |
| Sector (XLV) | 20.3% | 16.3% |
Fundamental Drivers
The -54.6% change in CCRN stock from 1/31/2025 to 2/11/2026 was primarily driven by a -42.6% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2112026 | Change |
|---|---|---|---|
| Stock Price ($) | 18.22 | 8.27 | -54.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,448 | 1,127 | -22.1% |
| P/S Multiple | 0.4 | 0.2 | -42.6% |
| Shares Outstanding (Mil) | 33 | 33 | 1.5% |
| Cumulative Contribution | -54.6% |
Market Drivers
1/31/2025 to 2/11/2026| Return | Correlation | |
|---|---|---|
| CCRN | -54.6% | |
| Market (SPY) | 16.0% | 16.4% |
| Sector (XLV) | 7.8% | 8.1% |
Fundamental Drivers
The -70.2% change in CCRN stock from 1/31/2023 to 2/11/2026 was primarily driven by a -60.0% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 1312023 | 2112026 | Change |
|---|---|---|---|
| Stock Price ($) | 27.75 | 8.27 | -70.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,819 | 1,127 | -60.0% |
| P/S Multiple | 0.4 | 0.2 | -34.7% |
| Shares Outstanding (Mil) | 37 | 33 | 14.1% |
| Cumulative Contribution | -70.2% |
Market Drivers
1/31/2023 to 2/11/2026| Return | Correlation | |
|---|---|---|
| CCRN | -70.2% | |
| Market (SPY) | 76.6% | 11.9% |
| Sector (XLV) | 22.6% | 7.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CCRN Return | 213% | -4% | -15% | -20% | -55% | 4% | -5% |
| Peers Return | 60% | -20% | 10% | -13% | -21% | 12% | 9% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 85% |
Monthly Win Rates [3] | |||||||
| CCRN Win Rate | 67% | 42% | 33% | 25% | 25% | 50% | |
| Peers Win Rate | 75% | 38% | 52% | 42% | 48% | 50% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | |
Max Drawdowns [4] | |||||||
| CCRN Max Drawdown | -2% | -43% | -32% | -57% | -59% | -0% | |
| Peers Max Drawdown | -3% | -31% | -19% | -24% | -34% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AMN, ENSG, ASGN, KFY, RHI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/11/2026 (YTD)
How Low Can It Go
| Event | CCRN | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -52.9% | -25.4% |
| % Gain to Breakeven | 112.4% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -59.1% | -33.9% |
| % Gain to Breakeven | 144.6% | 51.3% |
| Time to Breakeven | 291 days | 148 days |
| 2018 Correction | ||
| % Loss | -57.8% | -19.8% |
| % Gain to Breakeven | 137.0% | 24.7% |
| Time to Breakeven | 746 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -77.3% | -56.8% |
| % Gain to Breakeven | 339.8% | 131.3% |
| Time to Breakeven | 4,623 days | 1,480 days |
Compare to AMN, ENSG, ASGN, KFY, RHI
In The Past
Cross Country Healthcare's stock fell -52.9% during the 2022 Inflation Shock from a high on 10/28/2022. A -52.9% loss requires a 112.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Cross Country Healthcare (CCRN)
AI Analysis | Feedback
- Robert Half for healthcare professionals.
- Adecco for the medical industry.
AI Analysis | Feedback
- Travel Nurse and Allied Staffing: Provides temporary and contract nurses and allied health professionals to healthcare facilities nationwide.
- Physician Staffing: Offers locum tenens and permanent placement services for physicians and advanced practice professionals.
- Workforce Solutions: Delivers comprehensive managed services programs (MSPs) and recruitment process outsourcing (RPOs) to optimize staffing for healthcare systems.
AI Analysis | Feedback
Cross Country Healthcare (CCRN) primarily sells its services to other companies, specifically healthcare providers.
Its customer base is highly diversified, consisting of thousands of hospitals, health systems, and other healthcare facilities across the United States. Cross Country Healthcare provides staffing solutions, workforce management services, and other human capital solutions to these entities.
As per their public filings (e.g., annual 10-K reports), no single customer accounted for 10% or more of Cross Country Healthcare's consolidated revenues in recent years. This indicates that the company does not have a few 'major' customers in the traditional sense, but rather a large and fragmented customer base within the healthcare industry. Therefore, specific names of individual 'major customer companies' that would be disclosable are not identified.
AI Analysis | Feedback
null
AI Analysis | Feedback
John A. Martins, President and Chief Executive Officer
Mr. Martins has served as President and Chief Executive Officer of Cross Country Healthcare since April 2022. He joined the company in January 2021 as Group President, Nurse and Allied. With over 15 years of experience in the healthcare staffing industry, Mr. Martins previously served as Senior Vice President of Operations Strategy for Aya Healthcare, Inc. from November 2017 to January 2020. He also held the role of Senior Vice President, General Manager of AMN Healthcare Services, Inc. from January 2015 to October 2017, and was President of Onward Healthcare from February 2008 to January 2015. Onward Healthcare was acquired by AMN Healthcare in January 2015, where Mr. Martins subsequently became a Senior Vice President, General Manager. His expertise includes travel nurse and allied, per diem, locum tenens, and education staffing services, along with digital innovation and technology development.
William J. Burns, Executive Vice President and Chief Financial Officer
Mr. Burns is responsible for leading Cross Country Healthcare's finance, accounting & tax, treasury, procurement, investor relations, and shared services functions. He brings over 25 years of experience to his role and is a Certified Public Accountant. Prior to joining Cross Country Healthcare, Mr. Burns held leadership positions at Gartner, CA, Adecco, and Honeywell.
Kevin C. Clark, Co-Founder and Chairman
Mr. Clark co-founded Cross Country Healthcare Inc. in 1986, initially serving as Chairman and CEO until 1994, during which time the business was sold to W.R. Grace & Co. He returned as President and Chief Executive Officer of Cross Country Healthcare in January 2019, serving until March 2022, when he became non-executive Chairman. His extensive career includes co-founding Onward Healthcare in 2002, and leading Medefis and Locum Leaders, all of which were acquired in 2015. He also served as Chairman and Chief Executive Officer of Talivity, Inc. (2015-2018), OGH, LLC (2002-2015), Pinnacor Inc. (1999-2001), and Poppe Tyson, Inc. (1996-1998).
Susan E. Ball, J.D., MBA, RN, Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
Ms. Ball serves as the legal advisor to Cross Country Healthcare's CEO and board of directors, overseeing corporate governance, securities matters, risk management, workers' compensation, insurance, litigation, and mergers and acquisitions. Before embarking on her legal career, she was a Registered Nurse, providing her with unique insights into the company's legal matters. She also has extensive experience with public company issues.
Marc Krug, J.D., Group President, Delivery
Mr. Krug oversees the strategic vision and execution for Cross Country Healthcare's CCN, CCA, and CCMSN delivery brands, operations, and proprietary technology platforms.
AI Analysis | Feedback
The key risks to Cross Country Healthcare (CCRN) include a significant decline in demand for staffing services, regulatory uncertainty surrounding its pending acquisition, and competitive pressures leading to bill pay spread compression.
- Softening Demand for Travel and Local Staffing: Cross Country Healthcare is experiencing a substantial decline in market demand for travel and local staffing assignments, particularly within its Nurse and Allied segment. This post-pandemic contraction has led to significantly lower bill rates and a notable decrease in revenue and gross margins. The Nurse and Allied segment, a primary revenue driver, has seen a substantial year-over-year revenue decline, as hospitals prioritize permanent staffing and implement cost-containment measures.
- Regulatory Scrutiny and Uncertainty of Aya Healthcare Acquisition: The proposed acquisition of Cross Country Healthcare by Aya Healthcare faces heightened regulatory scrutiny from the Federal Trade Commission (FTC). This has resulted in an extended timeline for regulatory review and potential additional inquiries, creating significant uncertainty. The ongoing regulatory oversight has contributed to Cross Country Healthcare's stock trading at a discount relative to the announced deal price. Should the acquisition face prolonged delays or ultimately not be approved, it could adversely impact the company's standalone valuation and future strategic plans, as well as broader consolidation efforts within the healthcare staffing sector.
- Bill Pay Spread Compression due to Competition: The competitive nature of the healthcare staffing market, particularly in the Travel, Nurse, and Allied sectors, is leading to bill pay spread compression. Competitors often offer high compensation packages to attract clinicians, which puts pressure on the difference between what clients are willing to pay for services (bill rates) and what clinicians are paid (pay rates). This intense competition limits Cross Country Healthcare's ability to normalize its gross margins.
AI Analysis | Feedback
Clear Emerging Threats to Cross Country Healthcare (CCRN):
-
Rise of direct-to-facility and "gig economy" healthcare staffing platforms: A growing number of technology-first companies (e.g., Trusted Health, Clipboard Health, Gale Healthcare Solutions) are developing platforms that aim to disintermediate traditional healthcare staffing agencies. These platforms leverage AI, mobile apps, and direct contracting models to connect healthcare professionals directly with facilities, offering increased flexibility and potentially lower costs. This mirrors the disruption seen in industries like transportation (Uber vs. traditional taxis) and hospitality (Airbnb vs. hotels), posing a significant threat to CCRN's traditional intermediary business model.
-
Healthcare facilities' strategic initiatives to reduce reliance on temporary agency staff: Following the unprecedented costs incurred during the COVID-19 pandemic for temporary agency staff, many hospitals and health systems are actively implementing strategies to reduce their dependence on external staffing agencies. These initiatives include building robust internal float pools, enhancing retention programs, improving internal recruitment processes, and even establishing their own "internal travel nurse" programs. This strategic shift directly threatens the demand for CCRN's core services by reducing the addressable market for agency-provided staff.
-
Growing regulatory pressure and legislative efforts to cap agency rates: Several states have introduced or are actively considering legislation aimed at capping the rates that healthcare staffing agencies can charge hospitals or increasing transparency requirements around agency fees and profit margins. While the broad adoption and enforceability of such measures are still evolving, this trend represents a clear regulatory risk that could compress profit margins and alter the economic model for companies like CCRN, directly impacting their revenue and profitability.
AI Analysis | Feedback
Cross Country Healthcare, Inc. (CCRN) operates primarily in the healthcare staffing industry within the United States, offering talent management and consultative services. The company's main products and services fall into two primary segments: Nurse and Allied Staffing, and Physician Staffing.
Addressable Markets:
- U.S. Healthcare Staffing Market: This overarching market, encompassing all of Cross Country Healthcare's primary services, was valued at approximately USD 20.5 billion in 2022 and an estimated USD 23.6 billion in 2023. Projections indicate growth to approximately USD 34.7 billion by 2030, with a compound annual growth rate (CAGR) of 6.69% from 2023. Other reports estimate the U.S. healthcare staffing market size at USD 19.49 billion in 2024, growing to around USD 33.86 billion by 2034, at a CAGR of 5.68% from 2025 to 2034. Another source indicates the market size was USD 19.47 billion in 2024 and is predicted to increase from USD 21.59 billion in 2025 to approximately USD 40.16 billion by 2034, expanding at a CAGR of 5.71%.
- U.S. Travel Nurse Staffing Market: This segment dominated the U.S. healthcare staffing market, holding a share of 39.55% in 2022 and approximately 45.15% in 2024. The travel nursing market was estimated at about USD 5.6 billion in 2018 and was predicted to increase to USD 15.6 billion by 2023. It is expected to be the fastest-growing segment with a CAGR of 6.37%.
- U.S. Physician Staffing (Locum Tenens) Market: The locum tenens staffing segment is anticipated to experience significant growth. The global healthcare physician staffing market size was estimated at USD 30.32 billion in 2023 and is projected to reach USD 57.31 billion by 2033, growing at a CAGR of 6.57%. While this is a global figure, it indicates a substantial market for physician staffing that Cross Country Healthcare addresses in the U.S.
- U.S. Allied Health Staffing Market: Within the U.S. allied health temporary staffing sector, revenue decreased by 12.8% in the first half of 2024 compared to the first half of 2023. "Other allied health" occupations represented the largest market share at 22.6% of total allied staffing revenue in the first half of 2024. Specific market size figures for the entire U.S. allied health staffing market as a standalone entity are not explicitly provided in the search results, but it is a component of the broader U.S. healthcare staffing market.
AI Analysis | Feedback
Cross Country Healthcare (CCRN) is expected to navigate a mixed revenue landscape over the next two to three years, with overall revenue forecast to decline by analysts due to the normalization of the travel nurse market. However, several segments and strategic initiatives are identified as key drivers for future revenue growth within the company:
- Growth in Physician Staffing (Locum Tenens) Services: This segment has demonstrated consistent growth, with physician staffing revenue increasing 3.0% year-over-year in the second quarter of 2025. In the third quarter of 2024, physician staffing revenue was up 10% year-over-year and 4% sequentially, with analysts forecasting low double-digit growth for this business in 2024 and continued expansion in 2025, driven by an increase in billable days and higher revenue per day. Strategic acquisitions, such as those made in late 2022, have also contributed significantly to scaling this business.
- Expansion in Home Care Staffing: Cross Country Healthcare's home care revenue experienced substantial growth, rising more than 30% year-over-year in the second quarter of 2025. This segment represents a strong area of growth for the company as demand for in-home healthcare services continues to increase.
- Strategic Acquisitions: The company has a history of leveraging strategic acquisitions to bolster its service offerings and market share. An example of this is the announced acquisition of assets from Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC in September 2025, which aims to enhance its physician staffing capabilities.
- Managed Services Programs (MSPs) and Client Retention: Cross Country Healthcare reported steady client retention rates and a robust pipeline for new Managed Services Programs implementations and expansions in the latter half of 2025. These programs are crucial for optimizing workforce utilization and reducing operational costs for healthcare providers, fostering deeper client relationships and securing long-term service contracts.
AI Analysis | Feedback
Share Repurchases
- On May 1, 2023, the Board of Directors authorized an aggregate of $100.0 million in share repurchases under the Repurchase Program.
- Cross Country Healthcare repurchased over 2.4 million shares for $36.8 million in full-year 2024.
- As of June 30, 2025, $40.5 million remained authorized for share repurchase.
Share Issuance
- As of February 18, 2025, there were 32,812,580 shares of Common Stock outstanding.
- Performance Stock Awards were issued under the 2020 Omnibus Incentive Plan beginning March 31, 2021.
Inbound Investments
- Aya Healthcare announced the acquisition of Cross Country Healthcare for approximately $615 million in an all-cash transaction at $18.61 per share.
- This acquisition is anticipated to close in the second half of 2025, after which Cross Country Healthcare is expected to become a private company.
Outbound Investments
- On December 13, 2022, the company completed the acquisition of Hireup Leadership Inc.
- On June 8, 2021, Cross Country Healthcare completed the asset acquisition of Workforce Solutions Group, Inc. for $25.0 million in cash and $5.0 million in shares, with a potential earn-out of up to an additional $15.0 million.
Capital Expenditures
No specific dollar value for capital expenditures or expected capital expenditures for upcoming years was found in the provided information for the last 3-5 years.Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 34.83 |
| Mkt Cap | 2.3 |
| Rev LTM | 3,414 |
| Op Inc LTM | 183 |
| FCF LTM | 230 |
| FCF 3Y Avg | 257 |
| CFO LTM | 309 |
| CFO 3Y Avg | 360 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -6.1% |
| Rev Chg 3Y Avg | -6.5% |
| Rev Chg Q | -4.7% |
| QoQ Delta Rev Chg LTM | -1.2% |
| Op Mgn LTM | 4.2% |
| Op Mgn 3Y Avg | 6.4% |
| QoQ Delta Op Mgn LTM | -0.3% |
| CFO/Rev LTM | 9.0% |
| CFO/Rev 3Y Avg | 9.5% |
| FCF/Rev LTM | 5.7% |
| FCF/Rev 3Y Avg | 7.2% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 2.3 |
| P/S | 0.5 |
| P/EBIT | 7.9 |
| P/E | 13.2 |
| P/CFO | 7.4 |
| Total Yield | 5.0% |
| Dividend Yield | 0.1% |
| FCF Yield 3Y Avg | 9.2% |
| D/E | 0.2 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -4.1% |
| 3M Rtn | -2.0% |
| 6M Rtn | -16.7% |
| 12M Rtn | -33.4% |
| 3Y Rtn | -58.8% |
| 1M Excs Rtn | -3.6% |
| 3M Excs Rtn | 1.0% |
| 6M Excs Rtn | -21.4% |
| 12M Excs Rtn | -48.7% |
| 3Y Excs Rtn | -128.3% |
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Nurse and Allied Staffing | 1,841 | 2,700 | 1,606 | 768 | 733 |
| Physician Staffing | 178 | 106 | 71 | 68 | 75 |
| Search | 15 | ||||
| Total | 2,020 | 2,807 | 1,677 | 836 | 822 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Nurse and Allied Staffing | 197 | 355 | 206 | 74 | 64 |
| Physician Staffing | 10 | 6 | 4 | 4 | 3 |
| Acquisition and integration-related costs | -0 | ||||
| Impairment charges | -1 | -6 | -2 | -16 | -16 |
| Legal and other losses | -1 | ||||
| Restructuring costs | -3 | -2 | -3 | -6 | -4 |
| Depreciation and amortization | -18 | -13 | -10 | -13 | -14 |
| Corporate overhead | -71 | -67 | -55 | -52 | -46 |
| Legal settlement charges | 0 | -2 | |||
| Other costs | -1 | -1 | -0 | -0 | |
| Search | -1 | ||||
| Total | 113 | 273 | 139 | -9 | -16 |
Price Behavior
| Market Price | $8.27 | |
| Market Cap ($ Bil) | 0.3 | |
| First Trading Date | 10/25/2001 | |
| Distance from 52W High | -54.7% | |
| 50 Days | 200 Days | |
| DMA Price | $8.57 | $11.92 |
| DMA Trend | down | down |
| Distance from DMA | -3.5% | -30.6% |
| 3M | 1YR | |
| Volatility | 64.2% | 45.0% |
| Downside Capture | 166.01 | 86.01 |
| Upside Capture | -88.02 | -7.48 |
| Correlation (SPY) | 23.8% | 16.2% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.39 | 1.27 | 1.43 | 1.46 | 0.38 | 0.46 |
| Up Beta | 0.49 | 4.67 | 0.76 | 1.90 | 0.17 | 0.22 |
| Down Beta | 2.00 | 1.74 | 3.47 | 2.75 | 0.58 | 0.39 |
| Up Capture | 254% | -37% | -29% | 6% | 0% | 10% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 14 | 24 | 32 | 60 | 109 | 352 |
| Down Capture | -41% | 71% | 135% | 127% | 86% | 97% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 6 | 17 | 28 | 64 | 133 | 383 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -53.5% | 45.0% | -1.57 | - |
| Sector ETF (XLV) | 8.3% | 17.3% | 0.30 | 7.8% |
| Equity (SPY) | 15.5% | 19.3% | 0.62 | 16.2% |
| Gold (GLD) | 75.7% | 24.9% | 2.23 | 3.5% |
| Commodities (DBC) | 8.8% | 16.6% | 0.34 | 10.9% |
| Real Estate (VNQ) | 6.0% | 16.6% | 0.18 | 16.1% |
| Bitcoin (BTCUSD) | -29.3% | 44.7% | -0.64 | 10.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -2.6% | 59.7% | 0.18 | - |
| Sector ETF (XLV) | 7.9% | 14.5% | 0.36 | 17.3% |
| Equity (SPY) | 13.9% | 17.0% | 0.65 | 21.9% |
| Gold (GLD) | 22.9% | 16.9% | 1.10 | -0.9% |
| Commodities (DBC) | 11.4% | 18.9% | 0.49 | 1.3% |
| Real Estate (VNQ) | 5.1% | 18.8% | 0.18 | 18.4% |
| Bitcoin (BTCUSD) | 13.3% | 57.9% | 0.45 | 12.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -4.4% | 57.0% | 0.15 | - |
| Sector ETF (XLV) | 10.8% | 16.5% | 0.54 | 26.4% |
| Equity (SPY) | 15.6% | 17.9% | 0.75 | 30.3% |
| Gold (GLD) | 15.7% | 15.5% | 0.85 | -2.0% |
| Commodities (DBC) | 8.2% | 17.6% | 0.39 | 6.6% |
| Real Estate (VNQ) | 6.1% | 20.7% | 0.26 | 24.9% |
| Bitcoin (BTCUSD) | 68.7% | 66.7% | 1.08 | 8.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/12/2025 | -14.1% | -8.8% | -34.8% |
| 8/6/2025 | -4.4% | 0.1% | 7.6% |
| 3/5/2025 | -6.3% | -5.8% | -12.0% |
| 11/6/2024 | 1.0% | -16.9% | 48.8% |
| 7/31/2024 | -3.8% | -13.7% | -17.2% |
| 5/1/2024 | -6.5% | -8.0% | -15.5% |
| 2/21/2024 | -0.2% | 9.9% | 10.4% |
| 11/1/2023 | -13.8% | -19.4% | -10.4% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 8 | 10 |
| # Negative | 13 | 14 | 12 |
| Median Positive | 4.9% | 11.9% | 15.9% |
| Median Negative | -6.5% | -13.0% | -11.2% |
| Max Positive | 24.7% | 17.1% | 48.8% |
| Max Negative | -17.0% | -21.3% | -34.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/12/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 03/05/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/23/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
| 12/31/2021 | 02/28/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cash, W Larry | Direct | Buy | 12092025 | 8.17 | 5,000 | 40,829 | 1,670,995 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.